French Innovative Leukemia Organisation

This study tests a combination of two drugs, tagraxofusp and venetoclax, in adults with a rare blood cancer called BPDCN who have not had prior treatment. The main goal is to see if the combo leads to complete remission after three months. Participants will receive at least three…

This study tests whether adding ivosidenib to oral azacitidine (Onureg) can help prevent acute myeloid leukemia (AML) from returning in patients over 55 who have a specific IDH1 mutation and are already in remission after chemotherapy. About 60 participants will take both pills d…

This study tests a combination of two oral medications, zanubrutinib and BGB-11417, in people with Waldenström macroglobulinemia who have already received at least one prior treatment. The goal is to see if the combo can shrink or control the cancer better than current options. A…